58 results
PRE 14A
83vobnhgxt4qyv 2ti
4 Apr 22
Preliminary proxy
4:15pm
8-K
gwswnfkch
11 Jun 21
Invitae appoints technology and medtech veteran Roxi Wen as chief financial officer
8:03am
8-K
EX-1.1
mokk4j 58
4 May 21
Entry into a Material Definitive Agreement
5:15pm
8-K
EX-99.1
4t8oq5vc tje7u13
4 May 21
Invitae Reports $103.6 Million in Revenue Driven by 259,000 in Billable Volume in First Quarter of 2021
4:07pm
8-K
EX-10.1
1s6pn efx
23 Apr 21
Entry into a Material Definitive Agreement
5:25pm
8-K
EX-1.1
ngme5pd4 vvv
26 Jan 21
Invitae Announces Pricing of Public Offering of Common Stock
4:12pm
8-K
gfylvh1f
5 Nov 20
Invitae Reports $68.7 Million in Revenue Driven by 170,000 Samples Accessioned in the Third Quarter of 2020
4:24pm
8-K
EX-10.3
gxhptqepvxbu
5 Oct 20
Invitae Completes Transaction with ArcherDX to Bring Comprehensive Cancer Genetics and Precision Oncology to Patients Worldwide
4:17pm
424B3
b4l3al8dovrg cr5uvib
28 Aug 20
Prospectus supplement
4:31pm